Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc, Raltegravir, and Darunavir/Ritonavir in Triple Class Failure HIV
NCT01013987Phase 4Unknown
- Sponsor
- Fundación Huésped
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Fundación Huésped. Status: unknown.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01013987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01013987.